Abstract:Background Recent smooth muscle cell (SMC)-lineage tracing and single-cell RNA sequencing (scRNA-seq) experiments revealed a significant role of SMC-derived cells in atherosclerosis development. Further, thrombospondin-1 (TSP1), a matricellular protein, and activation of its receptor cluster of differentiation (CD) 47 have been linked with atherosclerosis. However, the role of vascular SMC TSP1-CD47 signaling in regulating VSMC phenotype and atherogenesis remains unknown. Methods We investigated the role of SMC CD47 activation by TSP1 in regulating VSMC phenotype and atherosclerosis development using various in vitro cell-based assays, molecular biological techniques, immunohistological approaches, reanalysis of publicly available scRNA-seq data, and cell-specific knockout mice. Results We observed elevated TSP1 expression in human atherosclerotic vascular tissues and VSMCs. TSP1-treated VSMCs exhibited decreased expression of contractile SMC markers ( ACTA2, CNN1 , and TAGLN ) and increased proliferation. Additional experiments and reanalysis of the scRNA-seq dataset showed CD47 as the major TSP1 receptor in VSMCs, with its expression increased in SMC-derived modulated cells of murine atherosclerotic arteries. Knockdown of CD47 gene in human VSMCs upregulated expression of contractile SMC markers and abrogated TSP1's effects on these genes. SMC-specific Cd47 deletion in mice suppressed atherosclerotic lesion formation, reduced macrophage accumulation, and decreased necrotic area. However, no significant differences were observed in weight gain, liver and adipose tissue mass, plasma total cholesterol, and fasting blood glucose between control and SMC-restricted Cd47- deficient mice. Further experiments demonstrated increased efferocytosis of apoptotic CD47 -silenced VSMCs by macrophages. Conclusions These findings suggest that CD47 plays a crucial role in regulating VSMC phenotype, and SMC-specific- Cd47 deletion suppresses atherosclerosis. New and noteworthy VSMC phenotypic switching contributes to atherosclerosis development. The present study reports the novel observations that Cd47 levels are upregulated in phenotypically modulated SMCs within atherosclerotic arteries and targeted deletion of Cd47 specifically in SMCs attenuates atherosclerosis. Mechanistic in vitro investigations further showed that TSP1-CD47 signaling regulates VSMC phenotype. Therefore, targeting SMC CD47 represents a promising therapeutic target to suppress atherogenesis.

Loss of Myeloid Cell-Specific SIRPα, but Not CD47, Attenuates Inflammation and Suppresses Atherosclerosis

Smooth muscle cell-specific CD47 deletion suppresses atherosclerosis

Mir-378a Modulates Macrophage Phagocytosis And Differentiation Through Targeting Cd47-Sirp Alpha Axis In Atherosclerosis

Macrophage-restricted Tyrosine Phosphatase SHP2 is a Novel Anti-Atherosclerotic Regulator

Increased lymphocyte activation and atherosclerosis in CD47-deficient mice

CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing Efferocytosis

CD47 Masks Pro-Phagocytic Ligands in Cis on Tumor Cells to Suppress Antitumor Immunity

SIRPα–CD47 Immune Checkpoint Blockade in Anticancer Therapy

CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis

Simultaneously Blocking ANGPTL3 and CD47 Prevents the Progression of Atherosclerosis Through Regulating Lipid Metabolism, Macrophagic Efferocytosis and Lipid Peroxidation

CD47-SIRPα signaling-inspired engineered monocytes for preventing the progression of atherosclerotic plaques

Abstract 128: Safety and Efficacy of Pro-efferocytic Nanoparticles to Treat Atherosclerosis in A Porcine Model

CD47 Activation by Thrombospondin-1 in Lymphatic Endothelial Cells Suppresses Lymphangiogenesis and Promotes Atherosclerosis

Cd47-Sirpα Interaction and IL-10 Constrain Inflammation-Induced Macrophage Phagocytosis of Healthy Self-Cells.

Sirpα on Tumor-Associated Myeloid Cells Restrains Antitumor Immunity in Colorectal Cancer Independent of Its Interaction with CD47

Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47

Abstract 5: Disruption of Semaphorin 7A Confers Protection Against the Development of Atherosclerosis

Myeloid Cell-Specific Serine Palmitoyltransferase Subunit 2 Haploinsufficiency Reduces Murine Atherosclerosis

Lack of SIRP-alpha Reduces Lung Cancer Growth in Mice by Promoting Anti-Tumour Ability of Macrophages and Neutrophils

Abstract 2067: Myeloid Cell Lgr4 Contributes to Atherosclerotic Lesion Formation

Attenuation of Phagocytosis of Xenogeneic Cells by Manipulating CD47.